CNS – RareMed – Patient Support Programs Under the Microscope: Do Your Programs Protect Patients? (=patient support programs)
As pharmaceutical products become more advanced and patient access grows more complex, patient support programs must evolve alongside them. Yet with that evolution comes a growing risk: ensuring that patient services remain compliant in an environment where the legal guardrails aren’t always clearly defined. To keep programs effective and aboveboard, manufacturers must proactively manage risk…
